http://nypost.com/2017/06/16/fda-approves-new-cheaper-alternative-to-epipen/ (http://nypost.com/2017/06/16/fda-approves-new-cheaper-alternative-to-epipen/)
And not an auto injector. I could not give this to DD. I really doubt she could self administer.
Reminds me of the Twinject second dose.
Quote from: PurpleCat on June 16, 2017, 07:47:02 AM
And not an auto injector. I could not give this to DD. I really doubt she could self administer.
I would not expect children to self administer it. And teachers here will not as it is against their collective agreement.
But, I would have been willing to purchase as the at-home epi for me to give my child. I've seen a picture of it.
This link has a picture of it.
http://m.digitaljournal.com/life/health/adamis-receives-fda-approval-for-a-less-costly-epipen-rival/article/495302 (http://m.digitaljournal.com/life/health/adamis-receives-fda-approval-for-a-less-costly-epipen-rival/article/495302)
So far only adult dosage has been approved.
Giving a non-auto injector to someone who has anaphalyactic shock occurring sounds fun, especially with a small child. The FDA Access data makes it clear that the syringe is totally exposed from the initial dose/entry (https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207534lbl.pdf). Have fun "slowly" inserting Symjepi into your child's thigh... (or your own!)
Non-autoinjector means there's also a bigger accidental prick/injection in unintended body part risk both before and after injection (especially after - EpiPen orange cap moves to cover needle as it is removed and Auvi-Q auto retracts).
Curious to see what the price point will be on Symjepi, it may help put downward price pressure on everything else if it's cheap enough.
Case looks big as does autoinjector, but without scale (they say the syringe fits in the palm of an adult) it's hard to gauge.
I think Windgap Medical's version (https://www.allergyeats.com/introducing-windgap-medical-and-the-future-of-epinephrine-autoinjectors/) of an autoinjector holds the most promise, if it can make it to market (they hope to apply to FDA in 2018). It's solid until the cap is removed, at which point the solution rehydrates to a solid. Meaning it tolerates a lot more temperature/handling conditions than liquid epinephrine in something "the size of a roll of quarters", with a much longer lifespan than liquid epinephrine too (years, not a year).
With swing and press (current instructions on epipen.ca site) it is easy to inject in the wrong place or wrong person. If you don't have another adult to hold the child, they can and have pulled their leg away.
And was it someone from here, or an article posted, that someone injected the epi into their own boob?
I agree an autoinjecter is easier and preferable. But for anyone without insurance, this could be a good option. Definitely better than a vial and needle. And definitey better than the Anakit.